Genetic Signatures (ASX:GSS) Other Gross PPE: A$1.40 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Genetic Signatures Other Gross PPE?

Genetic Signatures ASX:GSS Other Gross PPE is A$1.40 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

Genetic Signatures's Other Gross PPE for the quarter that ended in Jun. 2026 was A$1.40 Mil.

Genetic Signatures's quarterly Other Gross PPE declined from Jun. 2025 (A$1.40 Mil) to Dec. 2025 (A$0.00 Mil) but then increased from Dec. 2025 (A$0.00 Mil) to Jun. 2026 (A$1.40 Mil).

Genetic Signatures's annual Other Gross PPE stayed the same from Jun. 2024 (A$1.40 Mil) to Jun. 2025 (A$1.40 Mil) and stayed the same from Jun. 2025 (A$1.40 Mil) to Jun. 2026 (A$1.40 Mil).

Genetic Signatures Other Gross PPE Historical Data

* Premium members only.

The historical data trend for Genetic Signatures's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Signatures Other Gross PPE Chart

Genetic Signatures Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.00 1.40 1.40 1.40

Genetic Signatures Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 0.00 1.40 0.00 1.40

Genetic Signatures Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of A$1.40 Mil mean?
Genetic Signatures (ASX:GSS) has a Other Gross PPE of A$1.40 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Genetic Signatures and its competitors.
Is Genetic Signatures' Other Gross PPE too high?
Genetic Signatures' current Other Gross PPE is A$1.40 Mil.
How does Genetic Signatures' Other Gross PPE compare to TMO and DHR?
Genetic Signatures' Other Gross PPE of A$1.40 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Medical Diagnostics & Research company?
A good Other Gross PPE depends on the Medical Diagnostics & Research industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on Genetic Signatures and its competitors. Genetic Signatures's current Other Gross PPE is A$1.40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Signatures stock overvalued right now?
Based on GuruFocus' analysis, Genetic Signatures (ASX:GSS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.34, compared to a current price of A$0.09 — trading 74.4% below its estimated fair value. The current Other Gross PPE is A$1.40 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For Genetic Signatures (ASX:GSS), the current Other Gross PPE is A$1.40 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genetic Signatures Business Description

Address 7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.